Our results, based on 8 articles that included 10 case-control studies with 1,502 cases and 1,590 controls, suggested that the AXIN2 rs2240308 polymorphism increases the risk of cancer in a co-dominant model (GG vs. AA) and the recessive model, especially in lung cancer and Asian populations. Here, AXIN2 is linked to lung carcinoma.